THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS

The paper provides information on the safety and diagnostic efficacy of macrocyclic magnetic resonance contrast agents, such as gadobutrol, gadoteridol, and gadoteric acid. It is concluded that the standard gadobutrol dose of 0.1 mmol/kg body weight has a favorable safety profile and is well tolerat...

Full description

Bibliographic Details
Main Authors: V. O. Panov, N. L. Shimanovskiy
Format: Article
Language:English
Published: LUCHEVAYA DIAGNOSTIKA, LLC 2017-07-01
Series:Вестник рентгенологии и радиологии
Subjects:
Online Access:https://www.russianradiology.ru/jour/article/view/235
id doaj-84841e20419543c79ae7ca68e05f33c8
record_format Article
spelling doaj-84841e20419543c79ae7ca68e05f33c82021-09-15T15:32:23ZengLUCHEVAYA DIAGNOSTIKA, LLCВестник рентгенологии и радиологии0042-46762619-04782017-07-0198315916610.20862/0042-4676-2017-98-3-159-166179THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTSV. O. Panov0N. L. Shimanovskiy1Russian Medical Academy of Continuing Professional Education, Ministry of Health of the RussiaPirogov Russian National Research Medical University, Ministry of Health of the RussiaThe paper provides information on the safety and diagnostic efficacy of macrocyclic magnetic resonance contrast agents, such as gadobutrol, gadoteridol, and gadoteric acid. It is concluded that the standard gadobutrol dose of 0.1 mmol/kg body weight has a favorable safety profile and is well tolerated by children, including by newborn infants and adults. Owing to the increased relaxivity and double concentration of gadolinium, gadobutrol, as compared to gadoteridol and gadoteric acid, has a higher diagnostic efficacy and pharmacoeconomic advantages.https://www.russianradiology.ru/jour/article/view/235gadobutrolgadoteridolgadoteric acidmagnetic resonance imaging
collection DOAJ
language English
format Article
sources DOAJ
author V. O. Panov
N. L. Shimanovskiy
spellingShingle V. O. Panov
N. L. Shimanovskiy
THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
Вестник рентгенологии и радиологии
gadobutrol
gadoteridol
gadoteric acid
magnetic resonance imaging
author_facet V. O. Panov
N. L. Shimanovskiy
author_sort V. O. Panov
title THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
title_short THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
title_full THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
title_fullStr THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
title_full_unstemmed THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
title_sort diagnostic efficacy and safety of macrocyclic gadolinium-based magnetic resonance contrast agents
publisher LUCHEVAYA DIAGNOSTIKA, LLC
series Вестник рентгенологии и радиологии
issn 0042-4676
2619-0478
publishDate 2017-07-01
description The paper provides information on the safety and diagnostic efficacy of macrocyclic magnetic resonance contrast agents, such as gadobutrol, gadoteridol, and gadoteric acid. It is concluded that the standard gadobutrol dose of 0.1 mmol/kg body weight has a favorable safety profile and is well tolerated by children, including by newborn infants and adults. Owing to the increased relaxivity and double concentration of gadolinium, gadobutrol, as compared to gadoteridol and gadoteric acid, has a higher diagnostic efficacy and pharmacoeconomic advantages.
topic gadobutrol
gadoteridol
gadoteric acid
magnetic resonance imaging
url https://www.russianradiology.ru/jour/article/view/235
work_keys_str_mv AT vopanov thediagnosticefficacyandsafetyofmacrocyclicgadoliniumbasedmagneticresonancecontrastagents
AT nlshimanovskiy thediagnosticefficacyandsafetyofmacrocyclicgadoliniumbasedmagneticresonancecontrastagents
AT vopanov diagnosticefficacyandsafetyofmacrocyclicgadoliniumbasedmagneticresonancecontrastagents
AT nlshimanovskiy diagnosticefficacyandsafetyofmacrocyclicgadoliniumbasedmagneticresonancecontrastagents
_version_ 1717378766373650432